skip to main content

Main Site Navigation

Top of main content
Redefining CancerCare Around You.

Research and Clinical Trials

Involved in national research for more than 30 years, Carle Cancer Center offers its patients access to innovative ways to fight cancer through clinical trials. Clinical trials offer new insight into how to combat a disease like cancer and demonstrate new ways of preventing, treating, or possibly curing cancer.

Carle Cancer Center provides access to clinical trials for several types of cancer including but not limited to breast, lung, colon, melanoma, prostate, and ovarian cancer. We are also actively involved in national prevention clinical trials per cancer type. In addition, we offer symptom management program to address the quality of life of cancer patients.

Counseling and Programming Preferences for a Combined Nutrition and Physical Activity Intervention for Breast Cancer Survivors

This will be a cross-sectional survey study of MBCI breast cancer survivors. Recruitment and survey administration will occur during survivor’s routine MBCI appointments. The survey will include questions pertaining to history of participation in diet and exercise programming; interest in, preferences for and barriers to participating in such programming; demographic, clinical and lifestyle factors; and social cognitive constructs. Results will inform the development of programs that are tailored specifically to the Carle breast cancer survivor population with potential for immediate integration into the current survivorship care at MBCI and satellite clinics. A strong, multidisciplinary team of experts from Carle and UIUC whose collaboration and expertise in nutrition and exercise sciences, medical and surgical oncology and behavior change interventions are crucial to the success of this research and in creating the capacity for new initiatives.

Ex-vivo Optical Imaging of Breast Cancer Tissue and Benign Breast Specimens

This project investigates the use of non-invasive, label-free optical imaging techniques for imaging cancer to demonstrate the feasibility of different modalities for intraoperative detection and diagnosis.

Optical Spectroscopy and Imaging for Label-free Histopathology

This study will evaluate the capability of optical spectroscopy and imaging instruments to analyze freshly excised tissue, and determine diagnostically important features. Typically, during surgery, patient tissue is snap frozen and stained. The stained tissue is used for disease diagnosis, identifying margins, determining grade, stage, and disease progression. Use of frozen tissues introduces artifacts, takes longer time and requires multiple sections to ensure that the disease progression is accurately determined. Specialized staining such as immunohistochemistry can even take up to a few weeks, delaying decision making for therapy. Using optical spectroscopic imaging, we will be able to provide diagnostic information with minimal tissue processing and in a much shorter timeframe. This will enable improved and faster diagnosis leading to improvements in surgical outcomes. In addition, multiple stains can be obtained from a single optical spectroscopic image data, thus enabling multiplexing in terms of molecular information.


Meet Our Team

With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.



Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for cancer patients and their loved ones. With your support, we’ll continue to work to eliminate cancer through excellence in diagnosis, treatment, research and education. 


Related Events

Jan. 24, 2020
10:30 a.m.
Jan. 28, 2020
6 p.m.

Awards and Accreditations

Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.

    • National Accreditation Program for Breast Cancer
    • Commission on Cancer
    • ACR - Breast Ultrasound Accredited Company
    • QOPI Certified